DCGI Cautions Pharma Firms over Indirect Promotion of Obesity Drugs
The Drugs Controller General of India (DCGI) has issued an advisory warning pharmaceutical companies against the direct or indirect promotion…
Drugs Controller General of India
Read More
Centre Extends Tenure of Rajeev Singh Raghuvanshi as DCGI Amid Ongoing Regulatory Reforms
The Centre has approved a one-year extension for Rajeev Singh Raghuvanshi as India’s top drug regulator, effective March 1, allowing…
CDSCO Launches 100-day Awareness Drive on GST Reduction in MedTech Sector
The Central Drugs Standard Control Organisation (CDSCO) has initiated a 100-day nationwide awareness campaign highlighting the recent reduction in Goods…
Medical Device Industry Seeks Protection Amid Surge in Chinese Imports
The Association of Indian Medical Device Industry (AiMeD) has urged the government to take immediate steps to protect the domestic…
CDSCO Seeks Industry Feedback on Revised Classification of Cardio & Neuro Devices
The Central Drugs Standard Control Organisation (CDSCO) has released a draft document outlining the revised risk-based classification of cardiovascular and…